If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.
| pathogenic | likely pathogenic | uncertain significance | likely benign | benign | drug response | total |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 20 | 20 |
Gene and significance breakdown #
Total genes and gene combinations: 6
| Gene or gene combination | drug response | total |
|---|---|---|
| CYP2C9 | 6 | 6 |
| CYP2D6 | 6 | 6 |
| UGT1A, UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9 | 5 | 5 |
| MT-ND1, MT-RNR1 | 1 | 1 |
| MT-RNR1 | 1 | 1 |
| MT-RNR1, MT-TS1 | 1 | 1 |
Condition and significance breakdown #
Total conditions: 7
| Condition | drug response | total |
|---|---|---|
| Flurbiprofen response | 6 | 6 |
| Lesinurad response | 6 | 6 |
| Piroxicam response | 6 | 6 |
| Tamoxifen response | 6 | 6 |
| Deutetrabenazine response | 5 | 5 |
| Irinotecan response | 5 | 5 |
| Gentamicin response | 3 | 3 |